We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
Cap. Flow
-$1.08B
Cap. Flow %
-56.34%
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$13.6M
2
TSM icon
TSMC
TSM
+$11.4M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$11.3M
4
AMAT icon
Applied Materials
AMAT
+$9.44M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$6.99M

Top Sells

Rank Stock Value
1
KAHC
KKR Acquisition Holdings I Corp.
KAHC
+$30.7M
2
TWTR
Twitter, Inc.
TWTR
+$30.3M
3
Y
Alleghany Corp
Y
+$24.9M
4
CTXS
Citrix Systems Inc
CTXS
+$17M
5
ZEN
ZENDESK INC
ZEN
+$15.3M

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Technology 12.34%
3 Consumer Discretionary 8.56%
4 Industrials 7.99%
5 Healthcare 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLX icon
251
Sixth Street Specialty
TSLX
$1.81B
$1.64M 0.09%
92,194
+26,355
+40% +$473K
FTI icon
252
TechnipFMC
FTI
$27.3B
$1.64M 0.09%
134,222
-13,076
-9% -$146K
VRT icon
253
Vertiv
VRT
$105B
$1.62M 0.08%
118,861
+12,839
+12% +$171K
QUOT
254
DELISTED
Quotient Technology Inc
QUOT
$1.61M 0.08%
+470,494
New +$1.33M
BDXB
255
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
$1.61M 0.08%
32,169
– –
IDXX icon
256
Idexx Laboratories
IDXX
$46.2B
$1.61M 0.08%
3,936
+2,750
+232% +$1.07M
RH icon
257
RH
RH
$3.71B
$1.59M 0.08%
5,949
-7,392
-55% -$1.93M
PEPL
258
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$1.59M 0.08%
155,541
– –
LINC icon
259
Lincoln Educational Services
LINC
$1.3B
$1.58M 0.08%
272,992
– –
KVSA
260
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$1.58M 0.08%
158,242
-187,880
-54% -$1.86M
ATVI
261
PUT
DELISTED
Activision Blizzard
ATVI
$1.55M 0.08%
+20,200
New +$1.5M
POSH
262
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$1.54M 0.08%
+86,368
New +$1.53M
TCVA
263
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$1.54M 0.08%
153,752
– –
DNAB
264
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$1.54M 0.08%
152,618
– –
HROW icon
265
Harrow
HROW
$1.51B
$1.53M 0.08%
103,919
+18,828
+22% +$225K
ZURA icon
266
Zura Bio
ZURA
$566M
$1.53M 0.08%
150,000
– –
MRT icon
267
Marti Technologies
MRT
$150M
$1.53M 0.08%
150,000
– –
PDD icon
268
Pinduoduo
PDD
$131B
$1.52M 0.08%
18,667
-21,587
-54% -$1.5M
BMRN icon
269
BioMarin Pharmaceuticals
BMRN
$12.4B
$1.52M 0.08%
14,664
+11,052
+306% +$1.04M
QCRH icon
270
QCR Holdings
QCRH
$1.7B
$1.52M 0.08%
30,531
-1,483
-5% -$76.4K
NVSA
271
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$1.51M 0.08%
150,000
– –
SPOK icon
272
Spok Holdings
SPOK
$241M
$1.51M 0.08%
184,740
+58,496
+46% +$475K
FRC
273
DELISTED
First Republic Bank
FRC
$1.51M 0.08%
12,365
+4,632
+60% +$565K
AJRD
274
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$1.5M 0.08%
+26,896
New +$1.33M
VEEV icon
275
Veeva Systems
VEEV
$37.4B
$1.5M 0.08%
9,316
+539
+6% +$92.1K
9 10
11
12 13

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.

  • Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
  • Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
  • Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
  • Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
  • Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.